Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 4
1948 1
1949 1
1951 1
1953 1
1954 2
1956 3
1957 3
1958 2
1959 1
1960 3
1961 2
1962 3
1963 3
1964 7
1965 2
1966 2
1967 2
1968 3
1969 3
1970 6
1971 7
1972 5
1973 2
1974 4
1975 13
1976 7
1977 7
1978 8
1979 4
1980 6
1981 7
1982 7
1983 18
1984 13
1985 15
1986 14
1987 11
1988 10
1989 18
1990 28
1991 24
1992 34
1993 25
1994 29
1995 22
1996 23
1997 18
1998 30
1999 29
2000 16
2001 27
2002 35
2003 28
2004 27
2005 31
2006 38
2007 40
2008 32
2009 38
2010 40
2011 51
2012 46
2013 42
2014 47
2015 26
2016 33
2017 21
2018 22
2019 39
2020 41
2021 35
2022 34
2023 45
2024 36
2025 26
2026 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,310 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean liberman d[au] (160 results)?
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Among authors: silverman d. Ophthalmology. 2024 Aug;131(8):914-926. doi: 10.1016/j.ophtha.2024.02.014. Epub 2024 Feb 19. Ophthalmology. 2024. PMID: 38382813 Free article. Clinical Trial.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Among authors: silverman d. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.
Cancer-Associated Neurogenesis and Nerve-Cancer Cross-talk.
Silverman DA, Martinez VK, Dougherty PM, Myers JN, Calin GA, Amit M. Silverman DA, et al. Cancer Res. 2021 Mar 15;81(6):1431-1440. doi: 10.1158/0008-5472.CAN-20-2793. Epub 2020 Dec 17. Cancer Res. 2021. PMID: 33334813 Free PMC article. Review.
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Among authors: silverman d. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
Neuroendocrine circuit for sleep-dependent growth hormone release.
Ding X, Hwang FJ, Silverman D, Zhong P, Li B, Ma C, Lu L, Jiang G, Zhang Z, Huang X, Tu X, Tian ZM, Ding J, Dan Y. Ding X, et al. Among authors: silverman d. Cell. 2025 Sep 4;188(18):4968-4979.e12. doi: 10.1016/j.cell.2025.05.039. Epub 2025 Jun 24. Cell. 2025. PMID: 40562026 Free article.
Brainstem circuit for sickness-induced sleep.
Darmohray D, Sima J, Chen CH, Silverman D, Chen C, Xu A, Yao Y, Dan Y. Darmohray D, et al. Among authors: silverman d. Sci Adv. 2025 Dec 12;11(50):eady0245. doi: 10.1126/sciadv.ady0245. Epub 2025 Dec 10. Sci Adv. 2025. PMID: 41370374 Free PMC article.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Among authors: silverman d. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Loss of p53 drives neuron reprogramming in head and neck cancer.
Amit M, Takahashi H, Dragomir MP, Lindemann A, Gleber-Netto FO, Pickering CR, Anfossi S, Osman AA, Cai Y, Wang R, Knutsen E, Shimizu M, Ivan C, Rao X, Wang J, Silverman DA, Tam S, Zhao M, Caulin C, Zinger A, Tasciotti E, Dougherty PM, El-Naggar A, Calin GA, Myers JN. Amit M, et al. Among authors: silverman da. Nature. 2020 Feb;578(7795):449-454. doi: 10.1038/s41586-020-1996-3. Epub 2020 Feb 12. Nature. 2020. PMID: 32051587 Free PMC article.
Cardiovascular baroreflex circuit moonlights in sleep control.
Yao Y, Barger Z, Saffari Doost M, Tso CF, Darmohray D, Silverman D, Liu D, Ma C, Cetin A, Yao S, Zeng H, Dan Y. Yao Y, et al. Among authors: silverman d. Neuron. 2022 Dec 7;110(23):3986-3999.e6. doi: 10.1016/j.neuron.2022.08.027. Epub 2022 Sep 27. Neuron. 2022. PMID: 36170850 Free article.
1,310 results